Prem Watsa: Top Buys, Top Sells (Q4 2019)
Tuesday, March 24, 2020 · Johnny Hopkins
One of the best resources for investors are the publicly available 13F-HR documents that each fund is required to submit to the SEC. These documents allow investors to track their favorite superinvestors, their fund’s current holdings, plus their new buys and sold out positions. We spend a lot of time here at The Acquirer’s Multiple digging through these 13F-HR documents to find out which superinvestors hold positions in the stocks listed in our Stock Screeners.
As a new weekly feature, we’re now providing the top buys and sells from some of our favorite superinvestors based on their latest 13F-HR documents.
This week we’ll take a look at Prem Watsa (12-31-2019). The current market value of his portfolio is $2,538,895,000.
Top New Buys
| Stock | Shares Held | % Impact on Portfolio |
| FIT / Fitbit Inc. | 2,150,000 | 0.56 |
| TSX:QSR / Restaurant Brands Intern | 37,000 | 0.09 |
| MSG / The Madison Square Garden Company | 8,000 | 0.09 |
| CVS / CVS Health Corporation | 26,500 | 0.08 |
| CIGI / Colliers International Group Inc. | 25,000 | 0.08 |
Top Sells
| Stock | % Impact On Portfolio |
| ONCE / Spark Therapeutics, Inc. | 0.3 |
| NWPX / Northwest Pipe Co. | 0.07 |
| QTRHF / Quarterhill Inc | 0.05 |
| ICD / Independence Contract Drilling Inc | 0.04 |
| AP / Ampco-Pittsburgh Corp. | 0.01 |
Prem Watsa’s Latest Stock Portfolio: Fairfax’s Biggest Buys and Sells
Where Is the Deep Value in Small and Micro Caps This Week?
AI Stock Market Bubble: Can the Technology Succeed While Stocks Crash?